Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a positively-sense enveloped RNA virus belonging to the Coronaviridae family, is the main agent of the world-wide pandemic of Coronavirus disease (COVID-19) which has the largest genome among RNA viruses (approximately 30kb)[1]. SARS-CoV-2, formerly referred to as human coronavirus 2019 (HCoV-19) or 2019 novel coronavirus (2019-nCoV), was initially detected in Wuhan, Hubei, China in late 2019[2]. On January 30, 2020, the public health emergency of international concern (PHEIC) was declared by the World Health Organization (WHO), and finally COVID-19 was officially announced a pandemic on March 11, 2020[3]. Over 750 million positive cases and over 7 million deaths have been attributed to this pandemic globally, with Iran ranking as the 19th-highest country with 7,625,812 confirmed positive cases (WHO, January 16, 2024)[4].
The Latin word corona is where the word "coronavirus" originates, which means "wreath" or "crown" and refers to the distinctive appearance of virions[5]. Coronaviruses have the ability to infect humans and a wide range of animals (avian species, livestock and other mammals), resulting in variety of disease with various severity[6]. These viruses can be the agent of mild respiratory symptoms (HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63) to severe respiratory infections (MERS-CoV, primary SARS-CoV, and SARS-CoV-2) in humans[7]. As with other coronaviruses, SARS-CoV-2 also contains four structural proteins: E (envelope), M (membrane) S (spike), and N (nucleocapsid; As the RNA genome is protected by the N protein, the S, M, and E proteins form the viral envelope[8, 9]. SARS-CoV-2 infection occurs in humans primarily through the interaction of the viral S protein with the angiotensin-converting enzyme 2 (ACE2) receptors on a host cell's surface[10]. As each monomer of S protein assembles, which has about 1273 residues (depending on deletions in some variants), a clove-shaped trimer is formed, with three S1 heads and a trimeric S2 stalk. The N-terminal domain (NDT, residues 14–305) and receptor-binding domain (RBD, residues 319–541) are the two domains that are present in the SARS-CoV-2 S1 subunit. S2 subunit consists of fusion peptide (FP, residues 788–806) followed by two heptad repeats (HR1, residues 912–984 and HR2, residues 1163–1213), a transmembrane anchor (TA, residues 1213–1237) and the intracellular tail (IT, residues 1237–1273)[11–13].
The most common symptoms of COVID-19 caused by SARS-CoV-2 are rhinorrhea, cough, fever, dyspnea, and severe pneumonia[14]. Besides, the symptoms of long-term COVID-19 are extremely diverse, with many of them similar to those of the initial infection. These symptoms include loss of taste and smell, fatigue, hard breathing, muscle pain, dizziness and palpitations[15]. Additionally, diarrhea was a sign of gastrointestinal disorders in 2–10% of Covid-19 patients[16]. Moreover, a significant percentage of individuals may continue to develop no symptoms even after testing positive for SARS-CoV-2[17].
To identify the lineages that are currently in circulation, the Phylogenetic Assignment of Named Global Outbreak Lineages (PANGO) terminology is employed. Lineages starting with the letter A are belonged to the Wuhan/WH04/2020 variant, whereas lineages starting with the letter B are belonged to the Wuhan-Hu-1 variant, in a classification proposed by Rambaut et al.. A number value, such as A.2 or B.1, is allocated to the new SARS-CoV-2 lineages that are descended from lineages A or B[18]. Moreover, the emerging SARS-CoV-2 variants are classified into clades by Global Initiative on Sharing All Influenza Data (GISAID). After minor lineages merge into major clades, a clade is characterized by the statistical distribution of viral genome distance into phylogenetic groupings. As a result, the virus variants are categorized into eleven phylogenetic clusters, beginning with an early division of S, O and L, followed by an evolution of L into V and G, and then of G into GV, GH, and GR, and finally, GR into GRA and GRY[19, 20]. In addition, SARS-CoV-2 is classified into 37 main clades by Nextstrain: 19A, 19B, 20A-J, 21A-M, 22A-F and 23A-F. A clade is formed when a novel variant attains a worldwide frequency of 20%. The clade name for a new viral variant is determined by the year it first appears, and in this instance, it uses the alphabet's subsequent letter[21].
Coughing, sneezing, breathing, and other respiratory droplets released during close contact with an infected individual are the main ways that SARS-CoV-2 transmits from person to person[22]. Moreover, Furthermore, feces from infected individuals may contain significant amounts of SARS-CoV-2 (up to 108 genome copies per gram) due to the virus's ability to replicate in human intestinal enterocytes[23, 24]. According to Wu et al., SARS-CoV-2 may also continue to multiply for 11 days in patients' gastrointestinal tract even in acidic environment and even after respiratory tract samples are negative[25]. This opens a passage for viral RNA from human feces to wastewater and suggests a potential fecal-oral transmission route for this virus[26, 27]. are still unknown, there are increasing concerns about the risk of SARS-CoV-2 exposure in other water matrices mainly groundwater which is still used as the main source of drinking water, irrigation and other purposes in some areas. An improperly designed, constructed, maintained or located wastewater disposal systems can leak the contaminants especially viruses into the groundwater causing serious problems[28, 29]. In addition, the mass burial of COVID-19 victims' bodies raises the chance that the virus could spread more easily through soil water (Vadose zone) into groundwater[30].
The majority of studies conducted have concentrated on wastewater matrices. SARS-CoV-2 viral load in wastewater-related studies in Australia[31], Spain[32], USA[33], India[34], Chile[35], Czech Republic[36], France[37] and Brazil[38] ranged between 1.9×101 and 7.0×106 copies/L. Several studies have also investigated the possibility that this virus is present in river water[39–42], but not much research has been conducted regarding the potential for SARS-CoV-2 environmental contamination of other water matrices, particularly groundwater, that receive the discharge of untreated or treated wastewater. The SARS-CoV-2 RNA was eventually found in groundwater for the first time in Mexico by Mahlknecht et al[43].
In Iran, there are few surveillance studies concerning the SARS-CoV-2 RNA in groundwater[44]. However, wastewater has been the subject of several projects in this country. In a study by Amereh et al., SARS-CoV-2 RNA was identified in untreated sewage samples in Tehran between September 2020 until April 2021[45]. Moreover, Dargahi et al. detected and quantified the RNA of SARS-CoV-2 in wastewater collection networks, hospital wastewater, and five municipal wastewater treatment plants in Ardabil[46]. Also, a recent study conducted by Nasseri et al. has demonstrated that SARS-CoV 2 can be detected in treated and raw wastewater in three cities of Iran: Anzali, Qom and Tehran[47].
Based on this background and considering the emerging concern for fecal-oral SARS-CoV-2 transmission in groundwater, we assessed the presence of SARS-CoV-2 RNA in groundwater in Tehran using widely available quantitative polymerase chain reaction (qPCR) assay. In addition, the study aimed to conduct a survey of viral dissemination during an epidemic's peak phase and consider any potential effects on the environment and public health. This is the first study to report the SARS-CoV-2 RNA detection in the groundwater of Tehran, Iran.